Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab

NCT02888496 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT02888496
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02888496 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Caractérisation Des Anomalies Immunologiques au Cours de la Pseudopolyarthrite rhizomélique et Effets du Traitement Par Tocilizumab
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
January 31, 2015
Completion date
June 30, 2015
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polymyalgia rheumatica